| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_NFATC3_0014300 | Intron-Intron | chr16:68240986-68241600 | chr16:68207083-68207697 | 615 nt | 0.4780 |
| hsa_NFATC3_0014500 | Intron-Intron | chr16:68244109-68245520 | chr16:68210206-68211617 | 1412 nt | 0.4476 |
| hsa_NFATC3_0014400 | Intron-Exon-Intron | chr16:68244109-68249725 | chr16:68210206-68215822 | 250 nt | 0.4200 |
| hsa_NFATC3_0014700 | Intron-Exon-Intron | chr16:68248232-68250042 | chr16:68214329-68216139 | 1811 nt | 0.4329 |
| hsa_NFATC3_0014900 | Intron-Exon-Intron | chr16:68248232-68255187 | chr16:68214329-68221284 | 193 nt | 0.4404 |
| hsa_NFATC3_0014600 | Intron-Exon-Intron | chr16:68248232-68255288 | chr16:68214329-68221385 | 250 nt | 0.3960 |
| hsa_NFATC3_0014800 | Exon-Exon | chr16:68248232-68260462 | chr16:68214329-68226559 | 314 nt | 0.5096 |
| hsa_NFATC3_0015000 | Intron-Exon-Intron | chr16:68251614-68255187 | chr16:68217711-68221284 | 250 nt | 0.3520 |
| hsa_NFATC3_0015100 | Intron-Intron | chr16:68252015-68252355 | chr16:68218112-68218452 | 341 nt | 0.4692 |
| hsa_NFATC3_0015200 | Intron-Intron | chr16:68252020-68252355 | chr16:68218117-68218452 | 336 nt | 0.4673 |
A study in human peripheral whole blood samples selected the circNFATC3 for validation but eliminated it from the final age prediction model due to barely detectable expression (Ct >37) in RT-qPCR assays [Wang et al. DOI:10.3389/fgene.2022.1031806].